6-137878809-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001270508.2(TNFAIP3):c.1364G>A(p.Gly455Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001270508.2 missense
Scores
Clinical Significance
Conservation
Publications
- autoinflammatory syndrome, familial, Behcet-like 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary pediatric Behçet-like diseaseInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001270508.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFAIP3 | NM_001270508.2 | MANE Select | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | NP_001257437.1 | ||
| TNFAIP3 | NM_001270507.2 | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | NP_001257436.1 | |||
| TNFAIP3 | NM_006290.4 | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | NP_006281.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFAIP3 | ENST00000612899.5 | TSL:5 MANE Select | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | ENSP00000481570.1 | ||
| TNFAIP3 | ENST00000237289.8 | TSL:1 | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | ENSP00000237289.4 | ||
| TNFAIP3 | ENST00000420009.6 | TSL:3 | c.1364G>A | p.Gly455Glu | missense | Exon 7 of 9 | ENSP00000401562.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250216 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461748Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727178 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1364G>A (p.G455E) alteration is located in exon 7 (coding exon 6) of the TNFAIP3 gene. This alteration results from a G to A substitution at nucleotide position 1364, causing the glycine (G) at amino acid position 455 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at